Research Tracker›Biomarker Atlas›Migraine›25-Hydroxyvitamin D

25-Hydroxyvitamin D in Migraine

25-Hydroxyvitamin D belongs to the other group of Migraine markers and is reported to be decreased relative to healthy controls. The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The evidence summarised here comes from Liampas et al. 2020 and reflects averages across cohorts rather than any single patient's result.

↓ ReducedOther

Summary

Direction in Migraine↓ Reduced — lower than in the comparison group
CategoryOther
Compared againsthealthy controls
SourceLiampas et al. 2020 — doi:10.1016/j.neurol.2019.12.008
Condition atlasMigraine Biomarker Atlas

Other conditions where 25-Hydroxyvitamin D is reported

See the cross-condition hub: 25-Hydroxyvitamin D across conditions.

Related Other markers in Migraine

Full list: Migraine Biomarker Atlas.

Frequently asked questions

Is 25-Hydroxyvitamin D high or low in Migraine?

Reduced. Studies summarised in the OSMF atlas report lower 25-Hydroxyvitamin D in Migraine than in healthy controls. Source: Liampas et al. 2020.

Which test measures 25-Hydroxyvitamin D?

The atlas record does not list a standardised clinical test code (LOINC) for 25-Hydroxyvitamin D, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal 25-Hydroxyvitamin D result diagnostic of Migraine?

No. No single biomarker is diagnostic of Migraine. 25-Hydroxyvitamin D findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is 25-Hydroxyvitamin D specific to Migraine?

No. The same marker is also reported in Asthma, Low Back Pain, Major Depressive Disorder, Multiple Sclerosis in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). 25-Hydroxyvitamin D in Migraine: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/migraine/25-hydroxyvitamin-d.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from migraine.json · Browse: Migraine atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.